EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome

M Florencia Iulita iD, Alexandre Bejanin iD, Eduard Vilaplana, Maria Carmona-Iragui, Bessy Benejam, Laura Videla, Isabel Barroeta, Susana Fernández, Miren Altuna, Jordi Pegueroles, Victor Montal iD, Silvia Valldeneu und 24 weitere

Brain Communications · 02.03.2023 · 5 (2)

DOI: 10.1093/braincomms/fcad074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Communications, online erschienen am 17.03.2023. Verfasst von M Florencia Iulita und 35 weiteren Autor:innen. Beteiligte Einrichtung: Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de …. Die Arbeit wurde bisher 70-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Medical Research Council, Fondo de Investigaciones Sanitario, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study of sex differences in Alzheimer’s disease is increasingly recognized as a key priority in research and clinical development. People with Down syndrome represent the largest population with a genetic link to Alzheimer’s disease (>90% in the 7th decade). Yet, sex differences in Alzheimer’s disease manifestations have not been fully investigated in these individuals, who are key candidates for preventive clinical trials. In this double-centre, cross-sectional study of 628 adults with Down syndrome [46% female, 44.4 (34.6; 50.7) years], we compared Alzheimer’s disease prevalence, as well as cognitive outcomes and AT(N) biomarkers across age and sex. Participants were recruited from a population-based health plan in Barcelona, Spain, and from a convenience sample recruited via services for people with intellectual disabilities in England and Scotland. They underwent assessment with the Cambridge Cognitive Examination for Older Adults with Down Syndrome, modified cued recall test and determinations of brain amyloidosis (CSF amyloid-β 42 / 40 and amyloid-PET), tau pathology (CSF and plasma phosphorylated-tau181) and neurodegeneration biomarkers (CSF and plasma neurofilament light, total-tau, fluorodeoxyglucose-PET and MRI). We used within-group locally estimated scatterplot smoothing models to compare the trajectory of biomarker changes with age in females versus males, as well as by apolipoprotein ɛ4 carriership. Our work revealed similar prevalence, age at diagnosis and Cambridge Cognitive Examination for Older Adults with Down Syndrome scores by sex, but males showed lower modified cued recall test scores from age 45 compared with females. AT(N) biomarkers were comparable in males and females. When considering apolipoprotein ɛ4, female ɛ4 carriers showed a 3-year earlier age at diagnosis compared with female non-carriers (50.5 versus 53.2 years, P = 0.01). This difference was not seen in males (52.2 versus 52.5 years, P = 0.76). Our exploratory analyses considering sex, apolipoprotein ɛ4 and biomarkers showed that female ɛ4 carriers tended to exhibit lower CSF amyloid-β 42/amyloid-β 40 ratios and lower hippocampal volume compared with females without this allele, in line with the clinical difference. This work showed that biological sex did not influence clinical and biomarker profiles of Alzheimer’s disease in adults with Down syndrome. Consideration of apolipoprotein ɛ4 haplotype, particularly in females, may be important for clinical research and clinical trials that consider this population. Accounting for, reporting and publishing sex-stratified data, even when no sex differences are found, is central to helping advance precision medicine.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseDown syndromegenderprecision medicinesex

Autor:innen und Institutionen

  • Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona 08025, Spain.
  • Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid 28031, Spain.
  • Women's Brain Project, Guntershausen 8357, Switzerland.
  • Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona 08029, Spain.
  • Multidisciplinary Sleep Unit, Hospital de la Santa Creu i Sant Pau, Barcelona 08041, Spain.
  • Hospital del Mar, Barcelona 08003, Spain.

ORCID-Profile: M Florencia Iulita, Alexandre Bejanin, Victor Montal, Sandra Giménez, Ignacio Illán-Gala, Olivia Belbin, Henrik Zetterberg, Daniel Alcolea, Juan Fortea

Förderung

  • NIA NIH HHS
  • Medical Research Council
  • Fondo de Investigaciones Sanitario, Carlos III Health Institute
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
  • National Institutes of Health
  • Department de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innovació en Salut
  • Fundació La Marató de TV3
  • Wallenberg Scholar

Zitieren

APA

Iulita, M. F., Bejanin, A., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., Montal, V., Valldeneu, S., Giménez, S., González-Ortiz, S., Torres, S., El Bounasri El Bennadi, S., Padilla, C., Rozalem Aranha, M., Estellés, T., …, & Fortea, J. (2023). Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome. Brain Communications, 5(2). https://doi.org/10.1093/braincomms/fcad074

Vancouver

Iulita MF, Bejanin A, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, et al. Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome. Brain Communications. 2023;5(2). doi:10.1093/braincomms/fcad074

BibTeX
@article{Iulita2023,
  author = {Iulita, M Florencia and Bejanin, Alexandre and Vilaplana, Eduard and Carmona-Iragui, Maria and Benejam, Bessy and Videla, Laura and Barroeta, Isabel and Fernández, Susana and Altuna, Miren and Pegueroles, Jordi and Montal, Victor and Valldeneu, Silvia and Giménez, Sandra and González-Ortiz, Sofía and Torres, Soraya and El Bounasri El Bennadi, Shaimaa and Padilla, Concepcion and Rozalem Aranha, Mateus and Estellés, Teresa and Illán-Gala, Ignacio and Belbin, Olivia and Valle-Tamayo, Natalia and Camacho, Valle and Blessing, Esther and Osorio, Ricardo S and Videla, Sebastian and Lehmann, Sylvain and Holland, Anthony J and Zetterberg, Henrik and Blennow, Kaj and Alcolea, Daniel and Clarimón, Jordi and Zaman, Shahid H and Blesa, Rafael and Lleó, Alberto and Fortea, Juan},
  title = {Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome},
  journal = {Brain Communications},
  year = {2023},
  volume = {5},
  number = {2},
  doi = {10.1093/braincomms/fcad074}
}
Kostenlos starten →